Stability of activated partial thromboplastin time (APTT) test under different storage conditions
- PMID: 17607579
- DOI: 10.1080/10245330500397752
Stability of activated partial thromboplastin time (APTT) test under different storage conditions
Abstract
We designed this study to assess the effect of storage time and temperature on the activated partial thromboplastin time (APTT) test and plasma activity of factor VIII (FVIII). A total of 71 subjects, comprising 34 healthy controls and 37 patients receiving unfractionated heparin were enrolled. After centrifugation of collected specimens aliquots of plasma were stored at room temperature (20-22 degrees C), refrigerated at 2-6 degrees C and frozen at - 40 degrees C. Determination of APTT and plasma activity of FVIII were performed immediately after sampling (zero time) and after 6, 12 and 24 h. We found no significant difference in APTT after 6 h at room temperature and 4 degrees C compared to zero time values (P>0.05) in control group, while APTT was significantly changed at other storage conditions. With regard APTT test in patients on heparin therapy and samples for FVIII activity in healthy subjects; there was a statistically significant change in their results after 6, 12 and 24 h at room temperature, 4 and - 40 degrees C compared to zero time value(P < 0.05). Our data demonstrate that the APTT test can be done within 6 h when stored at room temperature and 4 degrees C without change in the result in healthy subjects. APTT test in patients on heparin therapy and samples for FVIII test in healthy subjects must be done immediately and without delay to avoid reduction in their activities.
Similar articles
-
Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.Thromb Haemost. 1987 Apr 7;57(2):226-31. Thromb Haemost. 1987. PMID: 3603414
-
Is it acceptable to use coagulation plasma samples stored at room temperature and 4°C for 24 hours for additional prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin, and D-dimer testing?Int J Lab Hematol. 2017 Oct;39(5):475-481. doi: 10.1111/ijlh.12664. Epub 2017 May 10. Int J Lab Hematol. 2017. PMID: 28488785
-
Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.Clin Chim Acta. 2000 Oct;300(1-2):13-21. doi: 10.1016/s0009-8981(00)00288-6. Clin Chim Acta. 2000. PMID: 10958859
-
Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.Lab Hematol. 2006;12(2):99-102. doi: 10.1532/LH96.05043. Lab Hematol. 2006. PMID: 16751138
-
Monitoring unfractionated heparin with the aPTT: time for a fresh look.Thromb Haemost. 2006 Nov;96(5):547-52. Thromb Haemost. 2006. PMID: 17080209 Review.
Cited by
-
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes.Thromb J. 2023 Feb 20;21(1):21. doi: 10.1186/s12959-023-00465-8. Thromb J. 2023. PMID: 36803983 Free PMC article.
-
Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaques.Naunyn Schmiedebergs Arch Pharmacol. 2012 Dec;385(12):1211-25. doi: 10.1007/s00210-012-0793-4. Epub 2012 Sep 16. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22983013 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous